Medical/Pharmaceuticals
U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China
SHANGHAI, March 7, 2026 /PRNewswire/ -- Jiahui International Cancer Center
(JICC) has stabilized a U.S. patient with advanced non‑small cell lung cancer
(NSCLC) and Parkinson's disease using ivonescimab, a novel immunotherapy
currently available only in China.
2026-03-07 13:12
5579
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio
* Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric cancers with high unmet needs. * Transaction represents total equity value of approximately $2.5 billion. SURESNES, France and BRISBANE, Calif., Marc...
2026-03-07 02:30
12173
CARsgen Therapeutics Announces 2025 Annual Results
SHANGHAI, March 6, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2025 Annual Results. Business Highlights * Cash and cash equivalents were around RMB1,123 million as of Decemb...
2026-03-06 20:03
10489
Insilico and TaiGen Achieve Milestone in Collaboration: Out-Licensed CKD Anemia Candidate ISM4808 Completes first human enrollment and dosing in Phase I clinical trial
CAMBRIDGE, Mass., March 5, 2026 /PRNewswire/ -- Insilico Medicine (Insilico Medicine, HKEX: 03696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced that ISM4808, an AI-driven PHD inhibitor for chronic kidney disease (CKD)-related anemia previou...
2026-03-06 18:53
6646
Sciwind Biosciences Announces Ecnoglutide Injection Approved by China's National Medical Products Administration (NMPA) for Chronic Weight Management
HANGZHOU, China, March 6, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced today that China's National Medical Products Administration (NMPA) has ...
2026-03-06 14:39
4506
Ceretone Launches in Australia with Flagship Core One Pro, Revolutionizing Access to Premium Hearing Solutions
MELBOURNE, Australia, March 6, 2026 /PRNewswire/ -- Ceretone
2026-03-06 08:00
3703
The world's largest brain research prize awarded for groundbreaking discoveries on how we sense touch and pain
The Brain Prize 2026 is awarded to Professors David Ginty (US) and Patrik Ernfors (Sweden) for their pioneering discoveries on how the nervous system detects and processes touch and pain. Their work has rewritten textbooks and opened new avenues for the development of targeted treatments for cond...
2026-03-05 23:00
Datasea Accelerates Global Commercialization of Acoustic + AI Health Care Robots, Expanding Scalable Applications in China and International Markets
Initial Technical Service Revenue Achieved as the Company Advances Global Deployment and Chain Expansion with Strategic Partner BEIJING, March 5, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in acoustic high-tech innovation and ...
2026-03-05 22:30
4780
Cerecin Announces TEDx Talk by CEO Dr. Charles Stacey is Now Available Online
Titled "The Potential of Fasting and Diet in the Future of Medicine" Highlighting the Potential of Ketones - from Fasting, the Ketogenic diet and Pharmaceuticals - to Address Neurological Disease and Improve Brain Health DENVER, Colo., March 5, 2026 /PRNewswire/ -- Cerecin Inc., a clinical-stage ...
2026-03-05 22:28
4180
Cadonilimab Achieves 100% 24-Month OS in Complete Responders in R/M Cervical Cancer Based on Long-Term Phase II Results
HONG KONG, March 4, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the latest long-term survival analysis data from the China pivotal registrational Phase II study (COMPASSION-03/AK104-201) of cadonilimab as a monotherapy for patients with recurrent or metasta...
2026-03-05 10:26
7860
Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint
A collaborative integration model to enable practical, scalable cell and gene therapy delivery. SINGAPORE, March 5, 2026 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT) today announced the launch of its new C> Ecosystem Blueprint — a practical, collaborative approach designed t...
2026-03-05 10:10
4307
Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference
TAIPEI, March 4, 2026 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) announced its participation in the 2026 International Patient and Scientific Conference hosted by the Kennedy's Disease Association (KDA). Held between February 27 and March 2, the conference served as a prem...
2026-03-05 09:47
5180
Lunit to Be Featured in 21 AI Imaging Studies on Breast Cancer and Lung Disease at ECR 2026
* 13 oral presentations included, reaffirming the clinical value of AI-based medical image analysis * Highlighting key topics such as early risk stratification based on AI abnormality scores and interval cancer classification SEOUL, South Korea, March 4, 2026 /PRNewswire/ -- Lunit (KRX:32813)...
2026-03-04 22:00
7121
Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
* Collaboration will evaluate Akeso's cadonilimab in combination with INOVIO's INO-5412 (INO-5401 plus INO-9012) as a potential treatment for glioblastoma (GBM), the most common and aggressive form of brain cancer * Novel combination therapy will be studied as part of the Phase II adaptive pl...
2026-03-04 21:52
8012
MGI Tech Announces Acquisition of STOmics and CycloneSEQ to Deliver Integrated Long-Read, Short-Read and Spatial Omics Solutions
SHENZHEN, China, March 4, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in the life sciences, today announced the acquisition of STOmics and CycloneSEQ. It marks a significant milestone in MGI's "SEQALL+GLI+Omi...
2026-03-04 11:58
5776
Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026
In Partnership with ATC Genomics, the Company Presented One of Asia's Largest Real-World Datasets (n=12,281) for AI-Powered Multi-Cancer Early Detection (MCED) and Showcased its Clinically Validated ctDNA-Powered Oncology Portfolio Across the Full Cancer Continuum for High-Risk and Hereditary Pop...
2026-03-04 10:00
9458
Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains
HOUSTON, March 3, 2026 /PRNewswire/ -- The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine composition, highlighting the continued spread of A(H3N2) subclade K and emerging B/Victoria lineage strains. In rapid response, Sin...
2026-03-04 09:53
7176
PROTECTHEALTH STRENGTHENS GOVERNANCE AND SERVICE CONTINUITY WITH ISO 22301 BCMS CERTIFICATION
CYBERJAYA, Malaysia, March 4, 2026 /PRNewswire/ -- ProtectHealth Corporation Sdn. Bhd. has reinforced its role as a key government agency and strategic purchaser of healthcare services with the successful attainment of the ISO 22301:2019/AMD1:2024 Business Continuity Management System (BCMS) Cert...
2026-03-04 08:44
5060
Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases
* Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting B cell-related autoimmune diseases. * Antengene will receive USD 80 million of upfront and near-term milestone payments, and is e...
2026-03-04 06:00
6238
iClever Joins Forces with Renowned Audiologist Kellsie Busho to Champion Children's Hearing Health on World Hearing Day 2026
NEWARK, N.J., March 3, 2026 /PRNewswire/ -- As digital learning and personal audio devices become central to childhood, experts warn of rising risks of preventable hearing damage. Marking World Hearing Day, iClever, the No.1 selling kids' headphone brand in the U.S. online market, today announced...
2026-03-04 00:08
7076
Week's Top Stories
Most Reposted
NOVVA Group acquires 120 MWp Philippines solar project, anchoring its AI-era power platform in Southeast Asia
[Picked up by 302 media titles]
2026-06-19 11:12
Vietnam Explores Sustainable Aviation Fuel Development at International Conference in Hanoi
[Picked up by 301 media titles]
2026-06-25 14:33
Affinidi and CardInfoLink Put the Missing Trust Layer for AI Agents into Production
[Picked up by 301 media titles]
2026-06-19 09:00
IPD and ABB Help Power Sustainable Operations at New Sydney Fish Market
[Picked up by 298 media titles]
2026-06-22 17:40
SPHERE AX Partners with U.S. AI Semiconductor Company Blaize at the National Assembly
[Picked up by 292 media titles]
2026-06-24 18:00
Most Read
Resilience Actions, a Re Sustainability Initiative, Launches ECOHUB.IN to Power India's Climate and Circular Economy Innovation Ecosystem
2026-06-19 19:33
6198
LEIFRAS Co., Ltd. Reports Financial Results for the First Quarter of Fiscal Year 2026
2026-06-19 04:00
5666
